Lytham Partners Spring 2024 Investor Conference Starts Tomorrow, May 30, 2024

PHOENIX and NEW YORK, May 29, 2024 - Lytham Partners, a leading investor relations and corporate access firm, today announced the schedule for its Spring 2024 Investor Conference taking place virtually on May 30, 2024. More than 40 companies will be available for virtual 1x1 meetings, and select companies will participate in webcast presentations. Participating companies include; Spire Global (NYSE: SPIR), Lincoln Educational Services (NASDAQ: LINC), Kiora Pharmaceuticals (NASDAQ: KPRX), Aytu BioPharma, Inc. (NASDAQ: AYTU) and Precision Optics Corporation (NASDAQ: POCI).

The conference also features 9 insightful discussion panels with industry-leading experts and investment professionals. See below for details.

To access company presentations and panel discussions or to schedule 1x1 investor meetings, please click here to register.

______________

CONFERENCE AGENDA

Thursday, May 30, 2024 - 8:00 am - 6:30 pm ET

• Keynote Speakers
• Fireside Chats & Webcast Presentations
• Round Table Discussions
• Virtual 1x1 Meetings

______________

KEYNOTE

• 9:00 am ET: Leading Portfolio Managers Discuss the State of Small and Micro Cap Markets

______________

ROUND TABLE DISCUSSIONS

• 10:45 am ET: Investing in a Higher Interest Environment: Ins and Outs of the Micro/SmallCap Marketplace
• 11:30 am ET: Analyst Insights into the Agriculture Sector
• 12:15 pm ET: Analyst Insights into the Environmental Industrials Sector
• 1:00 pm ET: Feeding the Planet – A VC’s View on Sustainable Solutions in a Lower Carbon Future
• 1:45 pm ET: CBOE: What you Need to Know About the New Equity Listing Alternative
• 2:30 pm ET: GPS for Alpha: Investing on a Global Basis
• 3:15 pm ET: T+1 Settlement is Here - What Market Participants Need to Know

To access company presentations and panel discussions or to schedule 1x1 investor meetings, please click here to register.

______________

PARTICIPATING COMPANY LIST

Healthcare

• ImmuCell Corporation (NASDAQ: ICCC)
• INVO Bioscience (NASDAQ: INVO)
• Reliq Health Technologies (OTC: RQHTF / TSXV: RHT)
• Scientific Industries, Inc. (OTCQB: SCND)
• Syra Health Corp. (NASDAQ: SYRA)
• Trinity Biotech plc (NASDAQ: TRIB)

Medical Device

• Beyond Air, Inc. (NASDAQ: XAIR)
• Delcath Systems (NASDAQ: DCTH)
• Modular Medical, Inc. (NASDAQ: MODD)
• NeurAxis, Inc. (NYSE American: NRXS)
• Zomedica Corp. (NYSE American: ZOM)

Commercial-Stage Pharma

• Aytu BioPharma, Inc. (NASDAQ: AYTU)
• Jaguar Health, Inc. (NASDAQ: JAGX)

Development-Stage Pharma

• Cadrenal Therapeutics (NASDAQ: CVKD)
• Dyadic International, Inc. (NASDAQ: DYAI)
• Kiora Pharmaceuticals (NASDAQ: KPRX)
• Reviva Pharmaceuticals (NASDAQ: RVPH)
• Shuttle Pharmaceuticals, Inc. (NASDAQ: SHPH)
• Unicycive Therapeutics, Inc. (NASDAQ: UNCY)

Basic Materials

• Arianne Phosphate (OTCQX: DRRSF / TSXV: DAN)
• Criterium Energy (TSXV: CEQ)
• Greenfire Resources (NYSE: GFR / TSX: GFR)

Industrials

• Arq, Inc. (NASDAQ: ARQ)
• Civeo Corp. (NYSE: CVEO)
• LiqTech International, Inc. (NASDAQ: LIQT)
• S&W Seed Company (NASDAQ: SANW)
• SenesTech, Inc. (NASDAQ: SNES)

 Consumer

• ChromaDex Corporation (NASDAQ: CDXC)
• Else Nutrition Holdings Inc. (OTCQX: BABYF / TSXV: BABY)
• Flow Beverage Corp. (OTCQX: FLWBF / TSX: FLOW)
• Lincoln Educational Services (NASDAQ: LINC)

Technology

• Beam Global (Nasdaq: BEEM)
• Bitcoin Well, Inc. (OTCQB: BCNWF / TSXV: BTCW)
• The Glimpse Group (NASDAQ: VRAR)
• GSE Systems, Inc. (NASDAQ: GVP)
• Lucas GC Limited (NASDAQ: LGCL)
• Mogo Inc. (NASDAQ: MOGO / TSX: MOGO)
• Peraso Inc. (NASDAQ: PRSO)
• Precision Optics Corporation (NASDAQ: POCI)
• SOBR Safe, Inc. (NASDAQ: SOBR)
• Spire Global (NYSE: SPIR)
• Zoomd Technologies (OTC: ZMDTF / TSXV: ZOMD)

To access company presentations and panel discussions or to schedule 1x1 investor meetings, please click here to register.